Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Chonnam Medical Journal|May 10, 2012
A Case of Painful Hashimoto Thyroiditis that Mimicked Subacute ThyroiditisHye Mi Seo, Miyeon Kim, Jaeseok Bae, et al.
Virchows Archiv : an International Journal of Pathology|November 20, 2009
Borderline and malignant phyllodes tumors display similar promoter methylation profilesJo-Heon Kim, Yoo Duk Choi, Ji Shin Lee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 19, 2020
Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity-a comparative study with papillary renal cell carcinomaSung Sun Kim, Yong Mee Cho, Gi Hwan Kim, et al.
Diagnostic Cytopathology|January 31, 2008
Effectiveness of sputum cytology using ThinPrep method for evaluation of lung cancerYoo-Duk Choi, Chang-Woo Han, Jo-Heon Kim, et al.
Skeletal Radiology|May 28, 2013
Giant cell tumor with secondary aneurysmal bone cyst: a unique presentation with an ossified extraosseous soft tissue massWon Sun Hong, Mi Sook Sung, Jo-Heon Kim, et al.
Cancer Research and Treatment|May 21, 2015
The Prognostic Significance of FGFR4 Gly388 Polymorphism in Esophageal Squamous Cell Carcinoma after Concurrent ChemoradiotherapyHyun-Jeong Shim, Min-Ho Shin, Hee-Nam Kim, et al.
Virchows Archiv : an International Journal of Pathology|May 25, 2010
Quantitative assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimensJo-Heon Kim, Yoo Duk Choi, Ji Shin Lee, et al.
Gynecologic Oncology|May 15, 2010
Evaluation of promoter hypermethylation detection in serum as a diagnostic tool for breast carcinoma in Korean womenJo-Heon Kim, Min-Ho Shin, Sun-Seog Kweon, et al.
Frontiers in Oncology|October 5, 2020
Frequency and Prognostic Value of IDH Mutations in Korean Patients With CholangiocarcinomaNah Ihm Kim, Myung-Giun Noh, Jo-Heon Kim, et al.
Virchows Archiv : an International Journal of Pathology|April 21, 2015
VE1 immunohistochemical detection of the BRAF V600E mutation in thyroid carcinoma: a review of its usefulness and limitationsJong-In Na, Jo-Heon Kim, Hye-Jeong Kim, et al.
Pageof 5